Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.62510717 |
2 | modulation by symbiont of host immune response (GO:0052553) | 7.62510717 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 7.62510717 |
4 | modulation by symbiont of host defense response (GO:0052031) | 7.62510717 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.62510717 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.62510717 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.25593067 |
8 | oligosaccharide catabolic process (GO:0009313) | 5.89616013 |
9 | glycosphingolipid catabolic process (GO:0046479) | 5.67993649 |
10 | response to peptidoglycan (GO:0032494) | 5.59798240 |
11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.46541074 |
12 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.45871692 |
13 | neutrophil activation involved in immune response (GO:0002283) | 5.43556129 |
14 | macrophage activation involved in immune response (GO:0002281) | 5.41290195 |
15 | positive regulation of interferon-alpha production (GO:0032727) | 5.12038028 |
16 | glycolipid catabolic process (GO:0019377) | 5.10581473 |
17 | response to host immune response (GO:0052572) | 5.09486981 |
18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.09486981 |
19 | amino sugar catabolic process (GO:0046348) | 5.09337925 |
20 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.89691351 |
21 | regulation of interferon-alpha production (GO:0032647) | 4.86911848 |
22 | ceramide catabolic process (GO:0046514) | 4.72653433 |
23 | microglial cell activation (GO:0001774) | 4.66418657 |
24 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.55511959 |
25 | response to host (GO:0075136) | 4.55511959 |
26 | response to host defenses (GO:0052200) | 4.55511959 |
27 | respiratory burst (GO:0045730) | 4.52074548 |
28 | immunoglobulin mediated immune response (GO:0016064) | 4.51261473 |
29 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.23044210 |
30 | regulation of macrophage chemotaxis (GO:0010758) | 4.16368026 |
31 | response to thyroid hormone (GO:0097066) | 4.04755134 |
32 | regulation of mononuclear cell migration (GO:0071675) | 3.98872141 |
33 | macrophage activation (GO:0042116) | 3.94547602 |
34 | detection of molecule of bacterial origin (GO:0032490) | 3.91708839 |
35 | myeloid cell activation involved in immune response (GO:0002275) | 3.91605862 |
36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.91012698 |
37 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.84171011 |
38 | T-helper 1 type immune response (GO:0042088) | 3.80481024 |
39 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.80432106 |
40 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.72917637 |
41 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.70814596 |
42 | positive regulation of interferon-beta production (GO:0032728) | 3.70738869 |
43 | reactive oxygen species biosynthetic process (GO:1903409) | 3.70447728 |
44 | superoxide anion generation (GO:0042554) | 3.67506749 |
45 | granulocyte activation (GO:0036230) | 3.66445578 |
46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.63817262 |
47 | I-kappaB phosphorylation (GO:0007252) | 3.59878617 |
48 | * regulation of cholesterol storage (GO:0010885) | 3.59696868 |
49 | N-acetylneuraminate metabolic process (GO:0006054) | 3.57382461 |
50 | membrane lipid catabolic process (GO:0046466) | 3.53907770 |
51 | response to muramyl dipeptide (GO:0032495) | 3.53518883 |
52 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.52556634 |
53 | natural killer cell mediated immunity (GO:0002228) | 3.52556634 |
54 | neutrophil activation (GO:0042119) | 3.48495789 |
55 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.47648055 |
56 | positive regulation of antigen processing and presentation (GO:0002579) | 3.47325867 |
57 | sphingolipid catabolic process (GO:0030149) | 3.46377515 |
58 | eosinophil migration (GO:0072677) | 3.45937394 |
59 | lymphocyte chemotaxis (GO:0048247) | 3.42416990 |
60 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.39552304 |
61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37345041 |
62 | cellular extravasation (GO:0045123) | 3.33803780 |
63 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.32520666 |
64 | negative regulation of interleukin-17 production (GO:0032700) | 3.32236942 |
65 | type I interferon signaling pathway (GO:0060337) | 3.31606469 |
66 | cellular response to type I interferon (GO:0071357) | 3.31606469 |
67 | positive regulation of mast cell activation (GO:0033005) | 3.31543145 |
68 | response to type I interferon (GO:0034340) | 3.29448039 |
69 | response to interferon-alpha (GO:0035455) | 3.27222753 |
70 | B cell mediated immunity (GO:0019724) | 3.26822625 |
71 | regulation of hypersensitivity (GO:0002883) | 3.25197535 |
72 | negative regulation of interleukin-12 production (GO:0032695) | 3.25191399 |
73 | keratan sulfate catabolic process (GO:0042340) | 3.24923724 |
74 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.24557100 |
75 | regulation of mast cell degranulation (GO:0043304) | 3.24466196 |
76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.23649570 |
77 | positive regulation of mast cell degranulation (GO:0043306) | 3.23649570 |
78 | positive regulation of heat generation (GO:0031652) | 3.22103832 |
79 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.18543071 |
80 | neutrophil mediated immunity (GO:0002446) | 3.17194175 |
81 | positive regulation of cholesterol efflux (GO:0010875) | 3.14649154 |
82 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.13713753 |
83 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.13239996 |
84 | ganglioside metabolic process (GO:0001573) | 3.10421845 |
85 | myeloid dendritic cell differentiation (GO:0043011) | 3.10024024 |
86 | regulation of monocyte chemotaxis (GO:0090025) | 3.09927784 |
87 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.09836758 |
88 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08318344 |
89 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.07476932 |
90 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.06637963 |
91 | regulation of mast cell activation (GO:0033003) | 3.05970572 |
92 | response to xenobiotic stimulus (GO:0009410) | 3.04890617 |
93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03954281 |
94 | leukocyte mediated cytotoxicity (GO:0001909) | 3.02813226 |
95 | regulation of chemokine biosynthetic process (GO:0045073) | 3.01447206 |
96 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.01123803 |
97 | vitamin D metabolic process (GO:0042359) | 3.00888425 |
98 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.00255979 |
99 | intracellular pH reduction (GO:0051452) | 3.00079324 |
100 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.99961049 |
101 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.98810890 |
102 | phagosome maturation (GO:0090382) | 2.97923081 |
103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97697037 |
104 | low-density lipoprotein particle clearance (GO:0034383) | 2.97561781 |
105 | positive regulation of macrophage cytokine production (GO:0060907) | 2.97407501 |
106 | positive regulation of lymphocyte migration (GO:2000403) | 2.97153404 |
107 | positive regulation of chemokine production (GO:0032722) | 2.97030531 |
108 | regulation of antigen processing and presentation (GO:0002577) | 2.96512838 |
109 | monocyte chemotaxis (GO:0002548) | 2.95438163 |
110 | apoptotic cell clearance (GO:0043277) | 2.94842119 |
111 | glucosamine-containing compound catabolic process (GO:1901072) | 2.92431129 |
112 | positive regulation of type 2 immune response (GO:0002830) | 2.91766325 |
113 | regulation of fever generation (GO:0031620) | 2.91243742 |
114 | cytokine secretion (GO:0050663) | 2.90708216 |
115 | low-density lipoprotein particle remodeling (GO:0034374) | 2.90354812 |
116 | negative regulation of lipid storage (GO:0010888) | 2.89535865 |
117 | pinocytosis (GO:0006907) | 2.89353845 |
118 | cellular response to interferon-alpha (GO:0035457) | 2.89154407 |
119 | neutrophil chemotaxis (GO:0030593) | 2.88652965 |
120 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88110047 |
121 | detection of external biotic stimulus (GO:0098581) | 2.87435553 |
122 | negative regulation of mast cell activation (GO:0033004) | 2.87330071 |
123 | germinal center formation (GO:0002467) | 2.87037196 |
124 | eosinophil chemotaxis (GO:0048245) | 2.86589002 |
125 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.86427828 |
126 | detection of other organism (GO:0098543) | 2.86397738 |
127 | cell adhesion mediated by integrin (GO:0033627) | 2.85265599 |
128 | regulation of integrin activation (GO:0033623) | 2.84140169 |
129 | positive regulation of leukocyte degranulation (GO:0043302) | 2.82983734 |
130 | myeloid leukocyte activation (GO:0002274) | 2.82435780 |
131 | myeloid dendritic cell activation (GO:0001773) | 2.82347879 |
132 | positive regulation of sterol transport (GO:0032373) | 2.82073168 |
133 | positive regulation of cholesterol transport (GO:0032376) | 2.82073168 |
134 | neutrophil migration (GO:1990266) | 2.80279061 |
135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.79985128 |
136 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.78779377 |
137 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.78691430 |
138 | negative regulation of cell killing (GO:0031342) | 2.78691430 |
139 | cellular response to ethanol (GO:0071361) | 2.77900653 |
140 | pH reduction (GO:0045851) | 2.73519363 |
141 | positive regulation of bone resorption (GO:0045780) | 2.71030606 |
142 | positive regulation of bone remodeling (GO:0046852) | 2.71030606 |
143 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70659257 |
144 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.70658252 |
145 | lysosome organization (GO:0007040) | 2.69284422 |
146 | lytic vacuole organization (GO:0080171) | 2.69284422 |
147 | osteoclast differentiation (GO:0030316) | 2.69111831 |
148 | cellular response to interferon-gamma (GO:0071346) | 2.67851914 |
149 | peptide catabolic process (GO:0043171) | 2.67360908 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.43883410 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.07525510 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.67492192 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.90742421 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.55268722 |
6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.31673212 |
7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.00538014 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.83084236 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.56988570 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16556819 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.05105915 |
12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.89554967 |
13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.81827854 |
14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59397816 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44641361 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43037510 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41137057 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38094798 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23448882 |
20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20575174 |
21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.18644951 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.14546945 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03624633 |
24 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.90289522 |
25 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.87068750 |
26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85716134 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83832665 |
28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83541064 |
29 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.80134011 |
30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77597852 |
31 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67680412 |
32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59604716 |
33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59421479 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55142208 |
35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51855309 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47281507 |
37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46672779 |
38 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46215026 |
39 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44710856 |
40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34959371 |
41 | MYB_26560356_Chip-Seq_TH2_Human | 1.34441714 |
42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33578756 |
43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32699467 |
44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31783895 |
45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30412812 |
46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27858257 |
47 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27518870 |
48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25690015 |
49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.24871270 |
50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23496386 |
51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21960389 |
52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20092472 |
53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.19055823 |
54 | MAF_26560356_Chip-Seq_TH1_Human | 1.19016034 |
55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16619787 |
56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16487450 |
57 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15460346 |
58 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11937127 |
59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11106623 |
60 | MYB_26560356_Chip-Seq_TH1_Human | 1.10695141 |
61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07045835 |
62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05985316 |
63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04634963 |
64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03897345 |
65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03323619 |
66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01795907 |
67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01345838 |
68 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98350301 |
69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97984229 |
70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97984229 |
71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97612054 |
72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97367426 |
73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96730673 |
74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96138076 |
75 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95695561 |
76 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94337387 |
77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93969506 |
78 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92640068 |
79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92562567 |
80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91001605 |
81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89420543 |
82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87605061 |
83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85945079 |
84 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85799162 |
85 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85746004 |
86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84551695 |
87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83568737 |
88 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82683231 |
89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81898419 |
90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81372354 |
91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80309884 |
92 | UTX_26944678_Chip-Seq_JUKART_Human | 0.76980660 |
93 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.76179487 |
94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75448864 |
95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.74419420 |
96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.73834214 |
97 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73693743 |
98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73133314 |
99 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73033696 |
100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72436181 |
101 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72403345 |
102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71984766 |
103 | CJUN_26792858_Chip-Seq_BT549_Human | 0.71012554 |
104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70746861 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70289322 |
106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69851886 |
107 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.69720336 |
108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.69720336 |
109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68478820 |
110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68333597 |
111 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67641926 |
112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.66239519 |
113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.64679395 |
114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.64250588 |
115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.63550488 |
116 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.63439421 |
117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.63341507 |
118 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.63025871 |
119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62981093 |
120 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.61786486 |
121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.59923344 |
122 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.59806491 |
123 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.59653510 |
124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.59276046 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.19429003 |
2 | MP0003436_decreased_susceptibility_to | 4.17772635 |
3 | MP0005058_abnormal_lysosome_morphology | 3.87642566 |
4 | MP0003303_peritoneal_inflammation | 3.74644317 |
5 | MP0009785_altered_susceptibility_to | 3.39175358 |
6 | * MP0002419_abnormal_innate_immunity | 3.28315097 |
7 | MP0002148_abnormal_hypersensitivity_rea | 3.22854191 |
8 | MP0006082_CNS_inflammation | 3.21091396 |
9 | MP0005000_abnormal_immune_tolerance | 3.07451377 |
10 | MP0002139_abnormal_hepatobiliary_system | 2.94466038 |
11 | MP0003724_increased_susceptibility_to | 2.84577802 |
12 | * MP0005025_abnormal_response_to | 2.82173828 |
13 | MP0003172_abnormal_lysosome_physiology | 2.69669606 |
14 | MP0001790_abnormal_immune_system | 2.60610159 |
15 | MP0005387_immune_system_phenotype | 2.60610159 |
16 | MP0000569_abnormal_digit_pigmentation | 2.52234778 |
17 | * MP0002452_abnormal_antigen_presenting | 2.46386903 |
18 | MP0001533_abnormal_skeleton_physiology | 2.33305875 |
19 | MP0001800_abnormal_humoral_immune | 2.30516399 |
20 | * MP0002723_abnormal_immune_serum | 2.27122681 |
21 | MP0005464_abnormal_platelet_physiology | 2.20077223 |
22 | MP0000685_abnormal_immune_system | 2.19637656 |
23 | MP0004510_myositis | 2.13269315 |
24 | MP0009840_abnormal_foam_cell | 2.08874401 |
25 | MP0003075_altered_response_to | 1.98358578 |
26 | MP0004947_skin_inflammation | 1.97306902 |
27 | * MP0001819_abnormal_immune_cell | 1.96478568 |
28 | * MP0002420_abnormal_adaptive_immunity | 1.93775447 |
29 | MP0009278_abnormal_bone_marrow | 1.91530125 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.91384009 |
31 | MP0000343_altered_response_to | 1.91281349 |
32 | MP0005671_abnormal_response_to | 1.90513823 |
33 | MP0009764_decreased_sensitivity_to | 1.89849082 |
34 | MP0003448_altered_tumor_morphology | 1.85663915 |
35 | MP0001845_abnormal_inflammatory_respons | 1.83349590 |
36 | MP0008469_abnormal_protein_level | 1.75928215 |
37 | MP0002405_respiratory_system_inflammati | 1.70890127 |
38 | MP0003690_abnormal_glial_cell | 1.67452007 |
39 | MP0003195_calcinosis | 1.63992096 |
40 | MP0003300_gastrointestinal_ulcer | 1.62947127 |
41 | MP0005365_abnormal_bile_salt | 1.57695021 |
42 | MP0005166_decreased_susceptibility_to | 1.51189152 |
43 | MP0003329_amyloid_beta_deposits | 1.50927576 |
44 | MP0002998_abnormal_bone_remodeling | 1.47948865 |
45 | MP0001853_heart_inflammation | 1.42841413 |
46 | MP0010155_abnormal_intestine_physiology | 1.41788910 |
47 | MP0003183_abnormal_peptide_metabolism | 1.39081161 |
48 | * MP0000604_amyloidosis | 1.38789632 |
49 | MP0002006_tumorigenesis | 1.34071857 |
50 | MP0000716_abnormal_immune_system | 1.33964942 |
51 | MP0001545_abnormal_hematopoietic_system | 1.30914528 |
52 | MP0005397_hematopoietic_system_phenotyp | 1.30914528 |
53 | MP0000858_altered_metastatic_potential | 1.28505366 |
54 | MP0005167_abnormal_blood-brain_barrier | 1.28404686 |
55 | MP0005310_abnormal_salivary_gland | 1.26198736 |
56 | MP0010307_abnormal_tumor_latency | 1.25087960 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.23112067 |
58 | MP0010386_abnormal_urinary_bladder | 1.22108956 |
59 | MP0003806_abnormal_nucleotide_metabolis | 1.18837508 |
60 | MP0005164_abnormal_response_to | 1.18802175 |
61 | MP0009763_increased_sensitivity_to | 1.18598056 |
62 | MP0005083_abnormal_biliary_tract | 1.17896317 |
63 | MP0002398_abnormal_bone_marrow | 1.14210186 |
64 | MP0008004_abnormal_stomach_pH | 1.12911339 |
65 | MP0000689_abnormal_spleen_morphology | 1.12466632 |
66 | MP0003566_abnormal_cell_adhesion | 1.12159692 |
67 | MP0005390_skeleton_phenotype | 1.07417627 |
68 | MP0005174_abnormal_tail_pigmentation | 1.06138558 |
69 | MP0002429_abnormal_blood_cell | 1.05402893 |
70 | MP0003828_pulmonary_edema | 1.04745073 |
71 | MP0004019_abnormal_vitamin_homeostasis | 1.04209282 |
72 | MP0002166_altered_tumor_susceptibility | 1.04131256 |
73 | MP0002277_abnormal_respiratory_mucosa | 1.03493315 |
74 | MP0005076_abnormal_cell_differentiation | 1.02962311 |
75 | MP0001851_eye_inflammation | 1.02782949 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 1.02709911 |
77 | MP0004782_abnormal_surfactant_physiolog | 1.01584770 |
78 | MP0002837_dystrophic_cardiac_calcinosis | 1.01245398 |
79 | MP0005647_abnormal_sex_gland | 0.97993604 |
80 | MP0002254_reproductive_system_inflammat | 0.97619125 |
81 | MP0006054_spinal_hemorrhage | 0.96986990 |
82 | MP0005451_abnormal_body_composition | 0.96866693 |
83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96824532 |
84 | MP0003186_abnormal_redox_activity | 0.96737901 |
85 | MP0001542_abnormal_bone_strength | 0.96512619 |
86 | MP0005257_abnormal_intraocular_pressure | 0.94320069 |
87 | MP0008438_abnormal_cutaneous_collagen | 0.92456762 |
88 | MP0002722_abnormal_immune_system | 0.92215928 |
89 | MP0003879_abnormal_hair_cell | 0.91138780 |
90 | MP0002877_abnormal_melanocyte_morpholog | 0.90846040 |
91 | MP0008260_abnormal_autophagy | 0.90673976 |
92 | MP0002933_joint_inflammation | 0.90548946 |
93 | MP0000249_abnormal_blood_vessel | 0.87445590 |
94 | MP0003633_abnormal_nervous_system | 0.85073825 |
95 | MP0000371_diluted_coat_color | 0.80832513 |
96 | MP0002138_abnormal_hepatobiliary_system | 0.79953163 |
97 | MP0003646_muscle_fatigue | 0.78201886 |
98 | MP0003091_abnormal_cell_migration | 0.77534057 |
99 | MP0003705_abnormal_hypodermis_morpholog | 0.77231721 |
100 | MP0000015_abnormal_ear_pigmentation | 0.76037296 |
101 | MP0005595_abnormal_vascular_smooth | 0.75423853 |
102 | MP0005646_abnormal_pituitary_gland | 0.71862507 |
103 | MP0005023_abnormal_wound_healing | 0.70526493 |
104 | MP0005165_increased_susceptibility_to | 0.70035336 |
105 | MP0003453_abnormal_keratinocyte_physiol | 0.69020235 |
106 | MP0002332_abnormal_exercise_endurance | 0.68867669 |
107 | MP0000465_gastrointestinal_hemorrhage | 0.68804737 |
108 | MP0002136_abnormal_kidney_physiology | 0.68355678 |
109 | MP0000609_abnormal_liver_physiology | 0.67935014 |
110 | * MP0003632_abnormal_nervous_system | 0.67854691 |
111 | MP0003795_abnormal_bone_structure | 0.67718887 |
112 | MP0005319_abnormal_enzyme/_coenzyme | 0.66572150 |
113 | MP0004858_abnormal_nervous_system | 0.66218107 |
114 | MP0004883_abnormal_blood_vessel | 0.65828432 |
115 | MP0001756_abnormal_urination | 0.64960110 |
116 | MP0003634_abnormal_glial_cell | 0.64287886 |
117 | MP0001958_emphysema | 0.64184732 |
118 | MP0001663_abnormal_digestive_system | 0.63381803 |
119 | MP0000767_abnormal_smooth_muscle | 0.62277936 |
120 | MP0002118_abnormal_lipid_homeostasis | 0.61185108 |
121 | MP0005197_abnormal_uvea_morphology | 0.60599660 |
122 | MP0002090_abnormal_vision | 0.59069020 |
123 | MP0008873_increased_physiological_sensi | 0.56763515 |
124 | MP0004130_abnormal_muscle_cell | 0.54669570 |
125 | MP0000920_abnormal_myelination | 0.53670495 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.74408420 |
2 | Recurrent bacterial skin infections (HP:0005406) | 7.06425003 |
3 | Eczematoid dermatitis (HP:0000976) | 6.87302526 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.72724931 |
5 | Systemic lupus erythematosus (HP:0002725) | 5.87428542 |
6 | Vacuolated lymphocytes (HP:0001922) | 5.36967361 |
7 | Abnormality of macrophages (HP:0004311) | 5.25524659 |
8 | Increased cerebral lipofuscin (HP:0011813) | 4.77476633 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 4.63181313 |
10 | Gingivitis (HP:0000230) | 4.44123821 |
11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.43211666 |
12 | Stomatitis (HP:0010280) | 4.36597040 |
13 | Recurrent skin infections (HP:0001581) | 4.16562125 |
14 | Glomerulonephritis (HP:0000099) | 4.15669989 |
15 | Autoimmune thrombocytopenia (HP:0001973) | 4.09684077 |
16 | Dysostosis multiplex (HP:0000943) | 3.92077683 |
17 | Axonal loss (HP:0003447) | 3.82982547 |
18 | Disinhibition (HP:0000734) | 3.82213536 |
19 | Mutism (HP:0002300) | 3.79868568 |
20 | Thick nail (HP:0001805) | 3.77468916 |
21 | Neurofibrillary tangles (HP:0002185) | 3.70763183 |
22 | Obstructive lung disease (HP:0006536) | 3.66326223 |
23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66326223 |
24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.64286048 |
25 | Pustule (HP:0200039) | 3.47621404 |
26 | Orchitis (HP:0100796) | 3.42135079 |
27 | Myositis (HP:0100614) | 3.38084636 |
28 | Periodontitis (HP:0000704) | 3.36629564 |
29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.32478443 |
30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.32478443 |
31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.32478443 |
32 | Myocardial infarction (HP:0001658) | 3.31113345 |
33 | Recurrent fungal infections (HP:0002841) | 3.29139959 |
34 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.24145233 |
35 | Mucopolysacchariduria (HP:0008155) | 3.24145233 |
36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.22913951 |
37 | Retrobulbar optic neuritis (HP:0100654) | 3.17098121 |
38 | Optic neuritis (HP:0100653) | 3.17098121 |
39 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.09226028 |
40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.09226028 |
41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.09226028 |
42 | Abnormality of complement system (HP:0005339) | 3.00633353 |
43 | Urticaria (HP:0001025) | 2.99891532 |
44 | Joint hemorrhage (HP:0005261) | 2.97181598 |
45 | Basal ganglia calcification (HP:0002135) | 2.89545804 |
46 | Complement deficiency (HP:0004431) | 2.86866969 |
47 | Vasculitis (HP:0002633) | 2.82587288 |
48 | Recurrent viral infections (HP:0004429) | 2.82166900 |
49 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70777867 |
50 | Cellulitis (HP:0100658) | 2.70691984 |
51 | Nephritis (HP:0000123) | 2.68601495 |
52 | Agnosia (HP:0010524) | 2.67902685 |
53 | Loss of speech (HP:0002371) | 2.66458564 |
54 | Retinal atrophy (HP:0001105) | 2.63829177 |
55 | Purpura (HP:0000979) | 2.62738557 |
56 | Abnormality of the periventricular white matter (HP:0002518) | 2.59959089 |
57 | Hematochezia (HP:0002573) | 2.59914890 |
58 | Metaphyseal irregularity (HP:0003025) | 2.57200956 |
59 | Tetraparesis (HP:0002273) | 2.56860610 |
60 | Interstitial pulmonary disease (HP:0006530) | 2.53512920 |
61 | Osteomyelitis (HP:0002754) | 2.46571048 |
62 | Pathologic fracture (HP:0002756) | 2.46465276 |
63 | Cerebral inclusion bodies (HP:0100314) | 2.42731660 |
64 | Hepatosplenomegaly (HP:0001433) | 2.42319602 |
65 | Upper motor neuron abnormality (HP:0002127) | 2.42062011 |
66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41583158 |
67 | Osteolytic defects of the hand bones (HP:0009699) | 2.41583158 |
68 | Xanthomatosis (HP:0000991) | 2.41397058 |
69 | Leukocytosis (HP:0001974) | 2.41149141 |
70 | Global brain atrophy (HP:0002283) | 2.39370312 |
71 | Recurrent pneumonia (HP:0006532) | 2.38214912 |
72 | Gingival bleeding (HP:0000225) | 2.38160656 |
73 | Pulmonary infiltrates (HP:0002113) | 2.34276152 |
74 | Premature loss of primary teeth (HP:0006323) | 2.32164066 |
75 | Nuclear cataract (HP:0100018) | 2.31670487 |
76 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.31660729 |
77 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29615400 |
78 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29615400 |
79 | Progressive neurologic deterioration (HP:0002344) | 2.28447634 |
80 | Neuronal loss in central nervous system (HP:0002529) | 2.27040562 |
81 | Arterial thrombosis (HP:0004420) | 2.22849724 |
82 | Bone pain (HP:0002653) | 2.18998798 |
83 | Meningitis (HP:0001287) | 2.15159867 |
84 | Amyloidosis (HP:0011034) | 2.15041455 |
85 | Dementia (HP:0000726) | 2.14896865 |
86 | J-shaped sella turcica (HP:0002680) | 2.14598021 |
87 | Abnormality of the lumbar spine (HP:0100712) | 2.13483543 |
88 | Increased CSF protein (HP:0002922) | 2.13458368 |
89 | Increased IgM level (HP:0003496) | 2.08228227 |
90 | T lymphocytopenia (HP:0005403) | 2.08141282 |
91 | Tubulointerstitial fibrosis (HP:0005576) | 2.03783787 |
92 | Increased serum ferritin (HP:0003281) | 2.02238968 |
93 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01403053 |
94 | Polyneuropathy (HP:0001271) | 2.00616677 |
95 | Spontaneous hematomas (HP:0007420) | 2.00444843 |
96 | Esophageal varix (HP:0002040) | 1.99960149 |
97 | Abnormality of T cell number (HP:0011839) | 1.98891353 |
98 | Skin nodule (HP:0200036) | 1.98515186 |
99 | Conjunctival telangiectasia (HP:0000524) | 1.98387733 |
100 | Progressive visual loss (HP:0000529) | 1.95521023 |
101 | Peripheral demyelination (HP:0011096) | 1.95287615 |
102 | Apathy (HP:0000741) | 1.94947714 |
103 | Diminished motivation (HP:0000745) | 1.93692308 |
104 | Nausea (HP:0002018) | 1.91161757 |
105 | Personality changes (HP:0000751) | 1.89905457 |
106 | Vertebral compression fractures (HP:0002953) | 1.89703315 |
107 | Hypercholesterolemia (HP:0003124) | 1.88964984 |
108 | Cardiomegaly (HP:0001640) | 1.87840980 |
109 | Inappropriate behavior (HP:0000719) | 1.85429906 |
110 | Epidermoid cyst (HP:0200040) | 1.83381350 |
111 | Thoracic kyphosis (HP:0002942) | 1.81473368 |
112 | Bone cyst (HP:0012062) | 1.80342980 |
113 | Anorexia (HP:0002039) | 1.80281086 |
114 | Albinism (HP:0001022) | 1.79762418 |
115 | Memory impairment (HP:0002354) | 1.79733084 |
116 | Epistaxis (HP:0000421) | 1.79048505 |
117 | Menorrhagia (HP:0000132) | 1.78761244 |
118 | Peritonitis (HP:0002586) | 1.78314407 |
119 | Keratoconjunctivitis sicca (HP:0001097) | 1.76405369 |
120 | Hemoptysis (HP:0002105) | 1.76363198 |
121 | Poor head control (HP:0002421) | 1.75610437 |
122 | Keratoconjunctivitis (HP:0001096) | 1.75270875 |
123 | Asymmetric septal hypertrophy (HP:0001670) | 1.74651416 |
124 | Hypergammaglobulinemia (HP:0010702) | 1.74466379 |
125 | Multiple enchondromatosis (HP:0005701) | 1.74419500 |
126 | Abnormality of iron homeostasis (HP:0011031) | 1.74287133 |
127 | Protuberant abdomen (HP:0001538) | 1.73885741 |
128 | Eosinophilia (HP:0001880) | 1.72033313 |
129 | Colitis (HP:0002583) | 1.71301726 |
130 | Splenomegaly (HP:0001744) | 1.70629271 |
131 | Paralysis (HP:0003470) | 1.68629012 |
132 | Agitation (HP:0000713) | 1.68581413 |
133 | Pulmonary fibrosis (HP:0002206) | 1.67332393 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.51126615 |
2 | MAP3K14 | 3.92016069 |
3 | BLK | 3.69020434 |
4 | TBK1 | 3.43955978 |
5 | ACVR1B | 3.33044674 |
6 | TYK2 | 3.26036372 |
7 | IRAK4 | 3.03404959 |
8 | PBK | 3.01566178 |
9 | IRAK3 | 3.00728323 |
10 | KIT | 2.77468058 |
11 | IKBKE | 2.54085892 |
12 | PDK2 | 2.40429386 |
13 | ERN1 | 2.21723536 |
14 | MAP4K1 | 2.04540964 |
15 | JAK1 | 2.02696073 |
16 | IKBKB | 2.01388818 |
17 | JAK3 | 1.97099973 |
18 | TAOK3 | 1.94019834 |
19 | TXK | 1.88756915 |
20 | MAP3K13 | 1.82652270 |
21 | DDR2 | 1.80372530 |
22 | CSK | 1.74361115 |
23 | FGR | 1.68715468 |
24 | NME2 | 1.63249271 |
25 | PIM2 | 1.60811367 |
26 | MST1R | 1.60417995 |
27 | CSF1R | 1.59190511 |
28 | NEK9 | 1.55771945 |
29 | HCK | 1.49913503 |
30 | ZAP70 | 1.36992398 |
31 | SYK | 1.36322367 |
32 | FES | 1.35396576 |
33 | LYN | 1.33513422 |
34 | MATK | 1.29948171 |
35 | BMX | 1.27850452 |
36 | CAMK1D | 1.26020430 |
37 | TGFBR2 | 1.24829398 |
38 | TTN | 1.21935202 |
39 | JAK2 | 1.17291974 |
40 | LCK | 1.14979056 |
41 | CHUK | 1.14626167 |
42 | RPS6KA4 | 1.13572495 |
43 | EPHB1 | 1.12986154 |
44 | CDC42BPA | 1.11299687 |
45 | RIPK1 | 1.04183532 |
46 | ABL2 | 1.04147707 |
47 | MARK3 | 0.96606530 |
48 | BTK | 0.95535160 |
49 | TAOK2 | 0.92618897 |
50 | STK10 | 0.89431730 |
51 | EGFR | 0.87165282 |
52 | PIM1 | 0.85751347 |
53 | GRK7 | 0.85741311 |
54 | BMPR2 | 0.83931236 |
55 | TLK1 | 0.82401559 |
56 | PRKCD | 0.82255248 |
57 | RPS6KA2 | 0.81507122 |
58 | MAP3K5 | 0.79747493 |
59 | TEC | 0.77894369 |
60 | FGFR4 | 0.77403869 |
61 | STK4 | 0.76678090 |
62 | FGFR3 | 0.76564362 |
63 | MST4 | 0.76479830 |
64 | DAPK2 | 0.75803801 |
65 | MAP2K3 | 0.75749329 |
66 | EIF2AK2 | 0.75328356 |
67 | FRK | 0.73485034 |
68 | MAP2K6 | 0.71910720 |
69 | CAMK1G | 0.71217861 |
70 | ABL1 | 0.71151239 |
71 | YES1 | 0.67986163 |
72 | CAMKK2 | 0.67760296 |
73 | RPS6KC1 | 0.66895566 |
74 | RPS6KL1 | 0.66895566 |
75 | ARAF | 0.62505105 |
76 | SIK2 | 0.61825822 |
77 | MAPK12 | 0.60431474 |
78 | STK3 | 0.60159099 |
79 | TGFBR1 | 0.59325855 |
80 | MAPK7 | 0.58530883 |
81 | SGK2 | 0.58283758 |
82 | TIE1 | 0.57011146 |
83 | SCYL2 | 0.56221852 |
84 | MAP3K11 | 0.55213047 |
85 | TAOK1 | 0.55206946 |
86 | TRPM7 | 0.54954299 |
87 | CDK6 | 0.53604232 |
88 | PTK6 | 0.53377164 |
89 | MOS | 0.52623885 |
90 | FYN | 0.51777147 |
91 | MAP3K3 | 0.50956696 |
92 | ITK | 0.50831389 |
93 | PINK1 | 0.48571929 |
94 | GRK1 | 0.47839838 |
95 | PLK2 | 0.47465733 |
96 | TESK2 | 0.47134763 |
97 | CLK1 | 0.46630271 |
98 | SGK3 | 0.46441856 |
99 | MAPK4 | 0.45850671 |
100 | DAPK3 | 0.45542375 |
101 | PDPK1 | 0.42736529 |
102 | INSR | 0.41009806 |
103 | LIMK1 | 0.40450567 |
104 | EPHA3 | 0.39578140 |
105 | PIK3CG | 0.39441636 |
106 | IGF1R | 0.39400244 |
107 | ERBB4 | 0.39239040 |
108 | MAPKAPK3 | 0.37762396 |
109 | PRKCQ | 0.37757592 |
110 | MAPK15 | 0.35357110 |
111 | ERBB3 | 0.34645789 |
112 | PDK1 | 0.34493963 |
113 | MAP3K1 | 0.34326509 |
114 | CAMKK1 | 0.34180826 |
115 | PRKACG | 0.34169049 |
116 | GSK3A | 0.33524945 |
117 | MET | 0.31940671 |
118 | LRRK2 | 0.31158734 |
119 | RPS6KA6 | 0.30258342 |
120 | DYRK1B | 0.29914838 |
121 | IRAK2 | 0.29519881 |
122 | PDGFRB | 0.28811886 |
123 | MAPKAPK2 | 0.27732346 |
124 | MAP3K10 | 0.27461950 |
125 | PKN2 | 0.26084517 |
126 | ADRBK2 | 0.24555607 |
127 | IRAK1 | 0.24453002 |
128 | SRC | 0.23526918 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.59848268 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.43857831 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.92172371 |
4 | Legionellosis_Homo sapiens_hsa05134 | 2.71857249 |
5 | Pertussis_Homo sapiens_hsa05133 | 2.68718965 |
6 | Lysosome_Homo sapiens_hsa04142 | 2.60558000 |
7 | Malaria_Homo sapiens_hsa05144 | 2.49237065 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44687012 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.39163600 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.38134799 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30867906 |
12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22917443 |
13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.21809872 |
14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19406515 |
15 | * Phagosome_Homo sapiens_hsa04145 | 2.14020978 |
16 | Other glycan degradation_Homo sapiens_hsa00511 | 2.04669904 |
17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.97257352 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86718702 |
19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86014201 |
20 | Measles_Homo sapiens_hsa05162 | 1.85399133 |
21 | Salmonella infection_Homo sapiens_hsa05132 | 1.77216428 |
22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75924915 |
23 | Influenza A_Homo sapiens_hsa05164 | 1.75008873 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.68493339 |
25 | Allograft rejection_Homo sapiens_hsa05330 | 1.61251768 |
26 | Asthma_Homo sapiens_hsa05310 | 1.56690890 |
27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55863673 |
28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54087632 |
29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43708290 |
30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34888671 |
31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33355488 |
32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32743933 |
33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.30650527 |
34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29963119 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27394244 |
36 | Apoptosis_Homo sapiens_hsa04210 | 1.26253364 |
37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26167251 |
38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25867872 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.24428204 |
40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17119183 |
41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13751813 |
42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11542126 |
43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11144315 |
44 | Amoebiasis_Homo sapiens_hsa05146 | 1.05967027 |
45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04347556 |
46 | Hepatitis C_Homo sapiens_hsa05160 | 1.01842872 |
47 | Prion diseases_Homo sapiens_hsa05020 | 1.00737300 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 0.96366727 |
49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95956712 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94934072 |
51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91870534 |
52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86439985 |
53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86308692 |
54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84724097 |
55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84164286 |
56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83694238 |
57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80333995 |
58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78952220 |
59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75297477 |
60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74916515 |
61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74600203 |
62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69438406 |
63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68733954 |
64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67956080 |
65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67515090 |
66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67070707 |
67 | Mineral absorption_Homo sapiens_hsa04978 | 0.58423019 |
68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56942773 |
69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56158646 |
70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54784369 |
71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53812636 |
72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52352157 |
73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51694430 |
74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50889646 |
75 | Platelet activation_Homo sapiens_hsa04611 | 0.50477353 |
76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49220762 |
77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48749364 |
78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48725167 |
79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48589774 |
80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46903496 |
81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45718721 |
82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45233384 |
83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44523539 |
84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43764106 |
85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41694553 |
86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39683357 |
87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38561605 |
88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37589397 |
89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37131653 |
90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36653149 |
91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34392690 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.34364867 |
93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34213992 |
94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33196606 |
95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32699678 |
96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32214672 |
97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30671894 |
98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.30293147 |
99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29333553 |
100 | Insulin resistance_Homo sapiens_hsa04931 | 0.26664867 |
101 | ABC transporters_Homo sapiens_hsa02010 | 0.24088065 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22781944 |
103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22027863 |
104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21903916 |
105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21471477 |
106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20571601 |
107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.19332421 |
108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19140372 |
109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18144444 |
110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17779409 |
111 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.15189131 |
112 | Renin secretion_Homo sapiens_hsa04924 | 0.14822783 |
113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.14541748 |
114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14522826 |
115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14218570 |
116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.13417302 |
117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11188276 |
118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09703237 |
119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.08354946 |
120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.05993565 |
121 | Bladder cancer_Homo sapiens_hsa05219 | 0.05870023 |